NO20056199L - Kaptoprilderivater - Google Patents
KaptoprilderivaterInfo
- Publication number
- NO20056199L NO20056199L NO20056199A NO20056199A NO20056199L NO 20056199 L NO20056199 L NO 20056199L NO 20056199 A NO20056199 A NO 20056199A NO 20056199 A NO20056199 A NO 20056199A NO 20056199 L NO20056199 L NO 20056199L
- Authority
- NO
- Norway
- Prior art keywords
- captopril
- captoprilnitro
- prophylaxis
- cardiovascular
- inflammatory
- Prior art date
Links
- FAKRSMQSSFJEIM-RQJHMYQMSA-N captopril Chemical compound SC[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O FAKRSMQSSFJEIM-RQJHMYQMSA-N 0.000 title 1
- 229960000830 captopril Drugs 0.000 title 1
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- 230000002526 effect on cardiovascular system Effects 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 208000017169 kidney disease Diseases 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyrrole Compounds (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03101553 | 2003-05-28 | ||
| PCT/EP2004/050899 WO2004106300A1 (en) | 2003-05-28 | 2004-05-24 | Captopril derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20056199L true NO20056199L (no) | 2006-02-13 |
Family
ID=33483995
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20056199A NO20056199L (no) | 2003-05-28 | 2005-12-27 | Kaptoprilderivater |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US7169805B2 (pt) |
| EP (1) | EP1626955A1 (pt) |
| JP (1) | JP4649410B2 (pt) |
| KR (1) | KR20060013413A (pt) |
| CN (1) | CN1795173A (pt) |
| AR (1) | AR044568A1 (pt) |
| AU (1) | AU2004242799A1 (pt) |
| BR (1) | BRPI0410020A (pt) |
| CA (1) | CA2527382A1 (pt) |
| MX (1) | MXPA05012758A (pt) |
| NO (1) | NO20056199L (pt) |
| PL (1) | PL379168A1 (pt) |
| RU (1) | RU2005135695A (pt) |
| WO (1) | WO2004106300A1 (pt) |
| ZA (1) | ZA200509459B (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200616604A (en) | 2004-08-26 | 2006-06-01 | Nicholas Piramal India Ltd | Nitric oxide releasing prodrugs containing bio-cleavable linker |
| KR20070053214A (ko) | 2004-08-26 | 2007-05-23 | 니콜라스 피라말 인디아 리미티드 | 신규 생분해성 링커를 함유하는 프로드럭 |
| WO2011160974A2 (en) | 2010-06-21 | 2011-12-29 | Nicox S.A. | Statin derivatives |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4105776A (en) * | 1976-06-21 | 1978-08-08 | E. R. Squibb & Sons, Inc. | Proline derivatives and related compounds |
| JPS559058A (en) | 1978-07-06 | 1980-01-22 | Dainippon Pharmaceut Co Ltd | 1-(3-mercapto-2-methylpropanoyl)prolyl amino acid derivative |
| US4399144A (en) * | 1980-04-30 | 1983-08-16 | John Wyeth And Brother Limited | Pyridinium salts |
| AU4200489A (en) | 1988-08-26 | 1990-03-23 | Sepracor, Inc. | Derivatives and precursors of captopril and its analogues |
| US5380758A (en) * | 1991-03-29 | 1995-01-10 | Brigham And Women's Hospital | S-nitrosothiols as smooth muscle relaxants and therapeutic uses thereof |
| GB2300635B (en) * | 1994-01-28 | 1998-06-17 | Cal Int Ltd | A pharmaceutical product comprising a salicylate of an esterifiable ace-inhibitor |
| UA58494C2 (uk) * | 1995-06-07 | 2003-08-15 | Зенека Лімітед | Похідні n-гетероарилпіридинсульфонаміду, фармацевтична композиція, спосіб одержання та спосіб протидії впливам ендотеліну |
| GB9517998D0 (en) * | 1995-09-04 | 1995-11-08 | Bioglan Lab Ltd | Compositions and device for their administration |
| IT1276071B1 (it) | 1995-10-31 | 1997-10-24 | Nicox Ltd | Compositi ad attivita' anti-infiammatoria |
| US6294517B1 (en) * | 1996-02-02 | 2001-09-25 | Nitromed, Inc. | Compositions and kits comprising alpha-adrenergic receptor antagonists and nitric oxide donors and methods of use |
| JPH09291075A (ja) * | 1996-03-01 | 1997-11-11 | Sankyo Co Ltd | チアゾリジン類 |
| US6331543B1 (en) * | 1996-11-01 | 2001-12-18 | Nitromed, Inc. | Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use |
| IT1295694B1 (it) | 1996-11-14 | 1999-05-27 | Nicox Sa | Nitrossi derivati per la preparazione di medicamenti ad attivita antitrombinica |
| IT1292426B1 (it) * | 1997-06-27 | 1999-02-08 | Nicox Sa | Sali nitrati di ace-inibitori |
| JPH1171279A (ja) | 1997-08-27 | 1999-03-16 | Sankyo Co Ltd | チアゾリジン類を有効成分として含有する狭心症予防剤又は治療剤 |
| US6223744B1 (en) * | 1999-03-16 | 2001-05-01 | Multi-Vet Ltd. | Wearable aerosol delivery apparatus |
| IT1311923B1 (it) | 1999-04-13 | 2002-03-20 | Nicox Sa | Composti farmaceutici. |
| IT1311924B1 (it) | 1999-04-13 | 2002-03-20 | Nicox Sa | Composti farmaceutici. |
| IT1314184B1 (it) | 1999-08-12 | 2002-12-06 | Nicox Sa | Composizioni farmaceutiche per la terapia di condizioni di stressossidativo |
| US6677356B1 (en) * | 1999-08-24 | 2004-01-13 | Medicure International Inc. | Treatment of cardiovascular and related pathologies |
| DK1216038T3 (da) * | 1999-08-30 | 2005-12-27 | Sanofi Aventis Deutschland | Anvendelse af inhibitorer af reninangiotensinsystemet ved forebyggelsen af cardiovaskulære hændelser |
| JP2003521496A (ja) * | 2000-01-26 | 2003-07-15 | ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー | Ａｃｅ阻害剤−バソプレッシンアンタゴニストの組み合わせ |
| EP1337283A4 (en) * | 2000-10-27 | 2005-05-18 | Nitromed Inc | METHOD FOR THE TREATMENT OF VASCULAR DISORDERS MARKED BY STICK OXIDE DEFICIENCY |
| ITMI20011240A1 (it) * | 2001-06-13 | 2002-12-13 | Nicox Sa | Farmaci per le vasculopatie |
-
2004
- 2004-05-20 US US10/849,560 patent/US7169805B2/en not_active Expired - Fee Related
- 2004-05-24 CA CA002527382A patent/CA2527382A1/en not_active Abandoned
- 2004-05-24 JP JP2006530215A patent/JP4649410B2/ja not_active Expired - Fee Related
- 2004-05-24 AU AU2004242799A patent/AU2004242799A1/en not_active Abandoned
- 2004-05-24 PL PL379168A patent/PL379168A1/pl not_active Application Discontinuation
- 2004-05-24 BR BRPI0410020-4A patent/BRPI0410020A/pt not_active IP Right Cessation
- 2004-05-24 KR KR1020057022245A patent/KR20060013413A/ko not_active Withdrawn
- 2004-05-24 EP EP04741637A patent/EP1626955A1/en not_active Withdrawn
- 2004-05-24 MX MXPA05012758A patent/MXPA05012758A/es active IP Right Grant
- 2004-05-24 RU RU2005135695/04A patent/RU2005135695A/ru not_active Application Discontinuation
- 2004-05-24 CN CNA2004800145185A patent/CN1795173A/zh active Pending
- 2004-05-24 WO PCT/EP2004/050899 patent/WO2004106300A1/en not_active Ceased
- 2004-05-27 AR ARP040101833A patent/AR044568A1/es unknown
-
2005
- 2005-11-22 ZA ZA200509459A patent/ZA200509459B/en unknown
- 2005-12-27 NO NO20056199A patent/NO20056199L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR20060013413A (ko) | 2006-02-09 |
| CA2527382A1 (en) | 2004-12-09 |
| RU2005135695A (ru) | 2006-05-27 |
| JP2006528230A (ja) | 2006-12-14 |
| PL379168A1 (pl) | 2006-07-24 |
| WO2004106300A1 (en) | 2004-12-09 |
| AU2004242799A1 (en) | 2004-12-09 |
| JP4649410B2 (ja) | 2011-03-09 |
| US20040259808A1 (en) | 2004-12-23 |
| EP1626955A1 (en) | 2006-02-22 |
| BRPI0410020A (pt) | 2006-04-25 |
| US7169805B2 (en) | 2007-01-30 |
| MXPA05012758A (es) | 2006-02-13 |
| CN1795173A (zh) | 2006-06-28 |
| ZA200509459B (en) | 2006-11-29 |
| AR044568A1 (es) | 2005-09-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200714590A (en) | Heterocyclic inhibitors of MEK and methods of use thereof | |
| CL2008001234A1 (es) | Compuestos derivados de heterociclos nitrogenados, inhibidores de las proteinas de apoptosis; y uso en el tratamiento del cancer. | |
| SI1827441T1 (sl) | Kombinacije za zdravljenje bolezni, povezanih s celično proliferacijo | |
| EA200870019A1 (ru) | Лактамовые соединения и способы их применения | |
| NO20070782L (no) | Tetrapeptidanaloger. | |
| IS7840A (is) | 3-(3,5-díoxó-4,5-díhýdró-3H-(1,2,4)tríasín-2-ýl)-bensamíð afleiður sem P2X7-hindrar til notkunar í meðferð á bólguvaldandi sjúkdómum | |
| LTC1830843I2 (lt) | Indolidono dariniai, skirti fibrozinių ligų gydymui arba prevencijai | |
| NO20054905D0 (no) | 2-acylamino-4-fenyltiazolderivater, fremgangsmate for deres fremstilling og anvendelse av de samme som i terapeutika | |
| IS7684A (is) | Ný efnasambönd, blöndur og aðferðir til að meðhöndla bólgusjúkdóma og -ástand | |
| NO20071095L (no) | Hittil ukjente tiofenderivater | |
| CL2009000200A1 (es) | Compuestos derivados de 2,7-naftiridinas-1-ona, mediadores de syk; composicion farmaceutica; y uso en el tratamiento de una enfermedad inflamatoria, respiratoria, proliferativa celular o autoinmune. | |
| DK1352897T3 (da) | Adamantanderivater til behandlingen af inflammatoriske sygdomme, immunsygdomme og cardiovaskulære sygdomme | |
| NO20082594L (no) | Pyrimidinylbenzotiofenforbindelser | |
| HRP20090498T1 (hr) | Kombinacija r,r-glikopirolata, roliprama i budesonida za liječenje upalnih oboljenja | |
| ATE448232T1 (de) | Substituierte heterozyklen | |
| WO2002060374A3 (en) | Benz-1,3-azole derivatives and their uses as heparanase inhibitors | |
| PH12020551573A1 (en) | Pharmaceutical compositions for inhibiting inflammatory cytokines | |
| DK1487828T3 (da) | Morpholinyl-urea-derivater til anvendelse til behandling af inflammatoriske sygdomme | |
| PL1692102T3 (pl) | Kompozycje i sposoby do wykrywania i leczenia chorób i stanów związanych z receptorami chemokiny | |
| CO5660287A2 (es) | Derivados de tetrahidrocarbazol y su uso farmaceutico | |
| UA91848C2 (ru) | Применение соединений диосметина в лечении и предотвращении тромботическим патологиям | |
| NO20074780L (no) | Heterocyklylamidsubstituerte imidazoler | |
| DK2185561T3 (da) | Derivater af 1,2,3,4-tetrahydropyrrolo(1,2-a)pyrazin-6-carboxamid og 2,3,4,5-tetrahydroprrolo(1,2-a)-diazepin-7-carboxamid, fremstilling deraf og terapeutisk anvendelse deraf | |
| MX2007011493A (es) | Modalidades antiinflamatorias. | |
| NO20056199L (no) | Kaptoprilderivater |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |